Bounce the New Basketball?
- Published in:
- JOPERD: The Journal of Physical Education, Recreation & Dance, 2007, v. 78, n. 1, p. 2
- Publication type:
- Article
Works matching Cuban, Mark, 1958-
Results: 22
1
2
Direct access testing ... the good and the bad.
- Published in:
- Medical Journal of Australia, 2015, v. 202, n. 7, p. 350
- Publication type:
- Article
3
“Thanks for Fighting the Good Fight”: Cultivating Dissent on Blogmaverick.com.
- Published in:
- Southern Communication Journal, 2009, v. 74, n. 4, p. 390, doi. 10.1080/10417940802650153
- By:
- Publication type:
- Article
4
A TALE OF TWO CITIES: MARK CUBAN, DAVID EINHORN, AND THE ETHICS OF INSIDER TRADING REFORM.
- Published in:
- Tennessee Journal of Law & Policy, 2020, v. 15, n. 1, p. 48
- By:
- Publication type:
- Article
5
THE New Kid On The Block: Todd Wagner And 2929 Entertainment.
- Published in:
- Metro, 2006, n. 151, p. 124
- By:
- Publication type:
- Article
6
Potential Impact of Mark Cuban Cost Plus Drug Company on Access to Prescription Drugs in Urology.
- Published in:
- AUANews, 2023, v. 28, n. 4, p. 18
- By:
- Publication type:
- Article
7
THE LAW AND ECONOMICS OF INSIDER TRADING.
- Published in:
- Wake Forest Law Review, 2015, v. 50, n. 5, p. 1155
- By:
- Publication type:
- Article
8
SPLOG! OR HOW TO STOP THE RISE OF A NEW MENACE ON THE INTERNET.
- Published in:
- Harvard Journal of Law & Technology, 2006, v. 20, n. 1, p. 467
- Publication type:
- Article
9
Selling fun and making a fortune: an examination of Mark Cuban's impact on sport and business.
- Published in:
- Sport in Society, 2020, v. 23, n. 9, p. 1535, doi. 10.1080/17430437.2020.1723833
- By:
- Publication type:
- Article
10
Reining in Maverick Traders: Rule 10b5-2 and Confidentiality Agreements.
- Published in:
- Texas Law Review, 2009, v. 88, n. 1, p. 195
- By:
- Publication type:
- Article
11
Interview with Mark Cuban.
- Published in:
- 2016
- By:
- Publication type:
- Interview
12
SEC V. CUBAN: THE MISAPROPRIATION THEORY AND ITS APPLICATION TO CONFIDENTIALITY AGREEMENTS UNDER SECTION 10(B) AND RULE 10B5-2 OF THE SECURITIES EXCHANGE ACT OF 1934.
- Published in:
- Delaware Journal of Corporate Law, 2010, v. 35, n. 2, p. 539
- By:
- Publication type:
- Article
13
(NOT SO) CLOSE, BUT NO CIGAR: THE SEC v. MARK CUBAN.
- Published in:
- 2012, isbn. 9780974664323
- By:
- Publication type:
- Case Study
14
(081) ACCESSIBILITY AND PRESCRIBING PATTERNS OF HORMONE THERAPIES AMONGST ISSWSH PROVIDERS.
- Published in:
- 2024
- By:
- Publication type:
- Abstract
15
(081) ACCESSIBILITY AND PRESCRIBING PATTERNS OF HORMONE THERAPIES AMONGST ISSWSH PROVIDERS.
- Published in:
- 2024
- By:
- Publication type:
- Abstract
16
(164) Potential Savings with Use of Cost Plus Pharmacy for Medical Treatment of Erectile Dysfunction.
- Published in:
- Journal of Sexual Medicine, 2024, p. 1, doi. 10.1093/jsxmed/qdae001.155
- By:
- Publication type:
- Article
17
(163) The High Price of Anonymity: Comparison of Cost of Direct-to-Consumer Mail Order Pharmacies Compared with Cost Plus Drug Company.
- Published in:
- Journal of Sexual Medicine, 2024, p. 1, doi. 10.1093/jsxmed/qdae001.154
- By:
- Publication type:
- Article
18
REGULATORY RITUALISM AND OTHER LESSONS FROM THE GLOBAL EXPERIENCE OF INSIDER TRADING LAW.
- Published in:
- University of Pennsylvania Journal of Business Law, 2021, v. 24, n. 1, p. 25
- By:
- Publication type:
- Article
19
A HEART AS FAR FROM FRAUD AS HEAVEN FROM EARTH: SEC V. CUBAN AND FIDUCIARY DUTIES UNDER RULE 10B5-2.
- Published in:
- Northwestern University Law Review, 2012, v. 106, n. 4, p. 1849
- By:
- Publication type:
- Article
20
Permanently Reviving the Temporary Insider.
- Published in:
- Journal of Corporation Law, 2011, v. 36, n. 2, p. 343
- By:
- Publication type:
- Article
21
Evidence-Based Cardiovascular Disease Medicines' Availability in Low-Cost Generic Drug Programs in the United States: A Cross-Sectional Study.
- Published in:
- Annals of Internal Medicine, 2023, v. 176, n. 9, p. 1190, doi. 10.7326/M23-0287
- By:
- Publication type:
- Article
22
Correction: Potential Medicare Part D Savings on Generic Drugs From the Mark Cuban Cost Plus Drug Company.
- Published in:
- Annals of Internal Medicine, 2022, v. 175, n. 9, p. 1342, doi. 10.7326/L22-0294
- Publication type:
- Article